Natural molecules from spider venom are considered potential drugs for diseases including cancer and pain, as well as the development of new biological insecticides for agricultural use. During coevolution in the long-term predator-prey game, spiders have formed a huge molecular diversity of toxins. As of March 1 of 2021, a total of 49,243 spider species had been described, but studies of venom have been performed in only a few hundred of these species due to the difficulty of collecting venom. Two technologies have helped partially dealing with this limitation in the recent past: the screening of cDNA libraries constructed from venom gland mRNAs and the heterologous expression of the coded peptides for functional characterization. In this study, transcriptomic analysis was performed to describe the predicted toxins of Sinopoda pengi (hereafter S. pengi) and Trichonephila clavata (hereafter T. clavata). The Trinity assembly result in 163,418 transcripts, 114,127 unigene of S. pengi and 125,099 transcripts, 87,084 unigene of T. clavata. A total of 22 and 24 unigenes were identified which were predicted to inhibitor cysteine knot (ICK) toxins from S. pengi and T. clavata, respectively. In summary, molecular templates with potential application value in medical and biological fields were obtained by classifying and characterizing presumed venom components, which lays a foundation for the further study of venom.